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Electrical charge is thought to be an important
factor in the integrity of the glomerular barrier to
filtration of macromolecules [1, 2]. Studies that
have explored the integrity of the glomerular barrier
to filtration have been done with heterologous trac-
er or probe proteins and with polysaccharide mac-
romolecules. Advantages to using the polysaccha-
ride macromolecules are: they are readily available;
they can be refined to give a defined molecular radi-
us; most importantly, they are neither reabsorbed
nor secreted by the tubules. But they are poly-
saccharides, and not proteins which are the natural-
ly occurring macromolecules. In addition, as point-
ed out by Rennke and Venkatachalam, molecular
conformational changes may facilitate their transit
across the glomerulus [3]. Thus, the charge on these
polysaccharide macromolecules can be controlled,
but not the changes in their structure.
Protein macromolecules of various molecular siz-
es have been used as tracers to study glomerular
transit [4—8], but these have had a wide range of
isoelectric points, and the importance of charge has
been appreciated fully only recently [7]. Although
heterologous protein tracer studies have provided
useful information [8], we believe it desirable to use
the naturally occurring plasma proteins as tracer
molecules.
In this study we examine albumin, the most abun-
dant protein in the plasma, the protein playing the
major role in oncotic pressure maintenance, and
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whose concentration in plasma is 40 mg/mi and in
urine is 10 mg/mi or less [9—11].
We have shown previously that normal human al-
bumin is handled by the rat kidney in a manner no
different from that of endogenous rat albumin [12].
The present study was designed to examine the ef-
fect of change in isoelectric point (p1) on renal han-
dling of the albumin molecule. Normal human albu-
min and two derivatives of human albumin with
higher isoelectric points were infused into rats un-
der conditions in which the renal handling of these
tracer molecules could be examined, while the renal
handling of endogenous rat albumin served as con-
trol.
Methods
Preparation of human albu,nin of increased isoe-
lectric points. Albumin derivatization was carried
out by the method of Hoare and Koshland [13]. This
reaction involved the activation of the carboxyl
groups of human albumin by a water soluble carbo-
diimide, l-ethyl-3-(3-dimethyl-amino-propryl)-car-
bodiimide hydrochloride (EDC; Pierce, Rockford,
Illinois), and the subsequent reaction of the activat-
ed carboxyl groups with a nucleophile, ethylene
diamine (EDA; Fisher Scientific Company, Fair
Lawn, New Jersey). EDA solution was prepared by
adding 66.8 ml of anhydrous EDA to 500 ml of dis-
tilled water, cooling the solution to 25° C and ad-
justing the solution to a pH of 4.75 with approxi-
mately 350 ml of 6 N hydrochloric acid. Eight millili-
ters of 25% human albumin (Cutter Laboratories,
Inc., Berkeley, California) was dialyzed against dis-
tilled water to remove preservatives and was added
to the EDA solution. The degree of EDA addition
(cationization) to the protein was regulated by the
amount of EDC added. To alter albumin so that the
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p1 was 5.5 to 6.6, we added 0.565 g of EDC (0.0064
M); to increase the p1 to 7.2 to 8.2, we used 0.725 g
(0.0082 M). The reaction continued for 120 mm and
was then quenched by the addition of 30 ml of 4 M
acetate buffer (pH, 4.75). The solution was dialyzed
at 4° C against several changes of distilled water,
lyophilized, redissolved in distilled water, dialyzed
again versus distilled water, and finally rely-
ophilized and stored at 4° C.
Characterization of cationized albumin. To dem-
onstrate that the altered species of albumin main-
tained cross reactivity with albumin and to charac-
terize them, we did the following procedures: (1)
immunoelectrophoresis in agarose, with barbital
buffer (pH, 8.7) in the Pfizer Poly E Film system
and with rabbit antihuman albumin antiserum (Beh-
ring Diagnostics, Sommerville, New Jersey); (2)
isoelectric focusing with the LKB 8100 column pre-
pared according to the instruction manual [14]
(LKB Instruments, Inc., Rockville, Maryland) and
the Lauda K-2/RD coolant system (Brinkmann In-
struments); (3) sodium dodecyl sulfate poly-
acrylamide gel electrophoresis, according to the
method of Laemli [15], with an acrylamide elec-
trophoresis cell (Savant Instruments, Inc., Hicks-
yule, New York) and with unaltered human albumin
used as the control; (4) Stokes radius (molecular
size) with a Sephadex G-l00 column calibrated with
blue dextran, human albumin, ovalbumin, and cyto-
chrome C.
Study of nephron transport of unaltered human
albumin and cationized human albumin. Experi-
ments were done in 14 female, Sprague-Dawley rats
(each weighing 200 to 260 g) obtained from a single
source. The rats were anesthetized intraperitoneal-
ly with mactin® (120 mg/kg) and placed on a heated
laboratory board; body temperature was main-
tained at 37° C by an external heat source and mon-
itored with a rectal thermistor and telethermometer.
The trachea was cannulated with a 10-mm length
of polyethylene (PE-lOO) tubing. Both femoral and
the left jugular veins were cannulated with PE-lO
tubing. Using Braun syringe pumps, we infused 3H-
inulin into the right femoral, normal saline into the
left, and the experimental albumin solution into the
jugular vein. We cannulated the left femoral artery
with PE-50 tubing to collect blood samples and to
monitor blood pressures with a Narco Biosystem
physiograph (desk model DMP-4B). The bladder
was exposed by laporatomy, and a funnel-shaped
piece of PE-60 tubing was tied securely into the ure-
thral orifice. Urine specimens were collected via
catheter into preweighed urine vials; completeness
of collection was insured by gentle direct bladder
compression.
In each experiment, there was an initial 60-mm
equilibration period during which normal saline was
infused at the rate of 3.75 mL/hr (62.5 dJmin) to
compensate for the insensible losses [16]. 3H-inulin
was administered in a priming dose of 4.5 Ci per
0.75 ml of normal saline per 1,5 mm, followed by a
continuous infusion of 3 Ci in 0.5 ml of normal sa-
line per hour. At the end of the two 30-mm control
periods, unaltered human albumin of p1 4.9 or al-
tered human albumin of p1 5.5 to 6.6 and p1 7.2 to
8.2 were infused into 5, 4, and 5 rats, respectively.
Forty milligrams of each albumin was dissolved in I
ml of normal saline and infused over 15 mm [12].
There were four 30-mm experimental periods. The
initial collection was started when the albumin in-
fusion was begun. Blood samples were drawn at the
midpoint of each collection period.
At the end of the experiment, the animals were
weighed, and a left nephrectomy was performed.
Tissue was quick frozen on an aluminum flag in iso-
pentane, precooled with liquid nitrogen, and stored
at —70° C for immunofluorescent microscopy. The
sections were incubated with fluorescein conjugat-
ed monospecific antisera to both human albumin
and rat albumin, with appropriate blocking and ab-
sorption controls. The findings were scored on a
semiquantitative scale (0 to 4+).
Chemical analysis of specimens. The urine vol-
ume collected during each of the six collection peri-
ods was measured by weighing. Urine and serum
sodium concentrations were measured in an In-
strument Laboratories flame photometer. Os-
molalities were measured on a Wescor 5100 vapor
pressure osmometer (Logan, Utah). 3H-inulin was
measured with a Packard liquid scintillation spec-
trometer.
Measurement of rat albumin and altered human
albumins. Albumin concentrations in serum and
urine were measured by the double antibody radio-
immunoassay technique [17]. Because the altered
human albumins cross reacted with the antisera, on-
ly the native human albumin was used as the radio-
labeled tracer. Rat albumin (p1, 4.9) and human al-
bumin (p1, 4.9) were radiolabeled by the chlora-
mine-T method with a Sephadex G-25 column and
sodium iodide 125J solution (Amersham, Arlington,
Illinois) [10].
For use in diluting the materials, the following so-
lutions were prepared: Phosphate-buffered saline
(PBS), pH of 7.4, was prepared by dissolving 1.13 g
of dibasic sodium phosphate, 0.258 g of monobasic
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potassium phosphate, and 8.5 g of sodium chloride
in 600 ml of water, with the final volume brought up
to I liter with water. For antigen dilution, a PBS-
ovalbumin buffer (pH, 7.4) was prepared by dis-
solving 50 mg of ovalbumin (grade V, Sigma, St.
Louis, Missouri) in 50 ml of PBS buffer. For anti-
body dilution, a diluent of 1/10 normal rabbit serum
in PBS-ovalbumin buffer (pH, 7.4) was prepared by
adding 1 part of normal rabbit serum to 9 parts of
PBS-ovalbumin.
Antiserum to rat albumin was prepared as pre-
viously described [10]. For use in the assay of hu-
man albumin, rabbit anti-human albumin was ob-
tained from Behring Diagnostics (Sommerville,
New Jersey). Goat antirabbit globulin served as the
second antibody, obtained through the courtesy of
Dr. Laxmi Srivastava, Division of Endocrinology,
University of Cincinnati Medical Center. The goat
antiserum was diluted 1: 10 in the PBS.
To determine the optimal antibody dilution for
each assay, we arranged a standard curve with 125J..
albumin diluted 1: 500 and standards of unlabeled
antigen containing between 62 and 1000 ng for
500, 1: 1000, 1: 5000, 1: 10,000, 1: 20,000 di-
lutions of antisera. The curve giving the most suit-
able displacement was then chosen. The albumin
derivatives did not readily displace the '251-labeled
human albumin in the radioimmunoassay. A signifi-
cantly greater amount of antigen was needed to
compete for the antibody. Thus, the assays for the
altered albumins were less sensitive, but were ade-
quate for almost all serum and urine samples.
Standard curves were constructed by adding 100
l (0.1 ml) of the 12I-albumin antigen, 100 pJ of ei-
ther antirat albumin or antihuman albumin, and 100
sl of the working solution containing either 10.0,
7.5, 5.0, 2.5, 1.25 or 0.625 tg/ml. Disposable Cor-
fling borosilicate culture tubes, 75 mm x 10 mm,
were used. Each sample was measured in duplicate.
For assay of rat albumin in serum, the serum was
diluted 1: 10,000 in ovalbumin-PBS. For assay of
human albumin and its derivatives in serum, the
serum was diluted 1: 1000 in ovalbumin-PBS. De-
termination of all albumins in urine was performed
on dilutions of I : 100 or greater. One hundred mi-
croliters of diluted serum or urine were handled
as working solution.
All tubes were then incubated at 37° C for 1 hour
and then incubated at 4° C overnight. One hundred
microliters of 1: 10 goat antirabbit globulin in PBS
then were added, incubated at 37° C for 1 hour, and
at 4° C for 4 hours.
Total radioactivity was then obtained in a Pack-
ard autogamma scintillation spectrometer. The test
tubes were then centrifuged in a Sorvall Superspeed
RC 2-B automatic refrigerated centrifuge at 3500
rpm (1500 g) for 30 mm at 4° C. The supernatant
was then suctioned off, and the precipitate was
counted in the gamma counter. Percentage binding
of 1251-rat albumin was then calculated, that is,
100 x count of precipitate — background
—
count of total — background
% bound.
A curve was constructed from the standard sam-
ples. After obtaining the fraction of radioactivity
bound in unknown samples, we determined albumin
concentrations from the standard curve. If the un-
known experimental sample had a concentration of
> 10 or < 0.1 jig/ml, the unknown experimental
sample was either further diluted or concentrated
and the assay was repeated. The assay had a coeffi-
cient of variation of 20%.
Lyophilized purified rat albumin and human albu-
min and derivatized human albumin were standard-
ized by weight. For rat and human albumin, the im-
munoreactivity was related to fresh rat serum albu-
min and fresh human serum albumin by determining
the albumin present after measuring the total pro-
tein with the Biuret reaction and the albumin frac-
tion by electrophoresis. The lyophilized albumin
values were corrected to the fresh serum values.
Statistical analysis. The results were studied by
covariance analysis [18]. All data, except for the al-
bumin concentration, UA1bV, CAIb, and the clear-
ance ratio for albumin (CA1b/CIfl x 100) were ex-
pressed as arithmetic means. Previous observations
in our laboratory have shown albumin concentra-
tions and UAIbV to be distributed normally logarith-
mically [12]. The data pertaining to CAIb and GFR
underwent logarithmic transformation before analy-
sis, and the data are expressed as geometric means.
The correlation coefficient of GFR, Crat Aib and
Chuman Mb were computed with the following covari-
ance model to remove the effects of differences be-
tween animals. For this analysis only those data
points containing complete observations on both rat
and human albumin were used. The model used
was:
= j + bX + R, + S(1) + RT1k + ijk1
where is the overall mean; X, is the covariate (in
the control periods for each rat); b is the coefficient
of the covariate; R1 is the treatment effect of the in-
fusion of human albumin and the two species of al-
tered human albumin; S(1) isjth rat tested within the
ith group; Tk is kth experimental time period; RTIk
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is treatment X time interaction; Cliki is error term
(RST)(l)k interaction).
Differences between the treatment groups were
tested by the Duncan test [18], with a level of signif-
icance ofF = 0.01.
Results
Characterization of albumin derivatives. The im-
munoelectrophoretic analysis of several albumin
preparations is shown in Fig. 1. The electrophoretic
migration of the cationized albumins was clearly al-
tered; the albumin derivatives retained immuno-
logic reactivity with the antialbumin serum. With
isoelectric focusing (Fig. 2), the majority of the ma-
terial for the two albumin derivatives reported here
did not migrate as a single band; rather, as observed
by Rennke et al in studies on ferritin and horse-
radish peroxidase, there was a distribution ranging
from 0.5 to 1 pH unit [3, 7]. No unaltered albumin
was found.
The physicochemical properties are summarized
in Table 1. Sodium dodecyl sulfate polyacrylamide
gel electrophoresis showed that no significant po-
lymerization of the albumin occurred as a result of
the derivatization procedure. The Stokes radius of
the two derivatized albumins (33 A) was slightly
less than that (35 A) of the unaltered albumin.
Results of infusion of albumin and albumin deriv-
atives. The results of a representative experiment in
which derivatized human albumin of p1 7.2 to 8.2
was infused are summarized in Table 2. Some of the
physiologic parameters measured are summarized
in Figs. 3 and 4.
Mean arterial blood pressure (MAP) was lower
throughout the experiment in animals that received
albumin of p1 5.5 to 6.6. There was no difference in
MAP in the other two groups of animals. MAP fell
after 3 hours in all groups. In animals infused with
unaltered human serum albumin (p1, 4.9), urine vol-
ume (V) increased during the last three experimen-
tal periods, GFR decreased; fractional free water
reabsorption was relatively constant, and fractional
osmolar clearance and fractional sodium excretion
increased during the experimental period, and par-
ticularly during the last two collection periods.
Broadly speaking, most of these parameters be-
haved similarly in animals infused with the two al-
bumin derivatives of p1 5.5 to 6.6 and p1 7.2 to 8.2.
Serum levels, urinary excretion rates, and frac-
tional clearances of rat albumin and of unaltered
and altered human albumins are summarized in Fig.
4. Unfortunately, the radioimmunoassay for human
albumin was not sufficiently sensitive to detect the
altered urinary albumin in the third and fourth ex-
perimental periods following infusion of the albu-
min derivative, p1 5.5 to 6.5. The results of the co-
variance analysis of the data on GFR and albumin
clearances are summarized in Table 3.
There was no significant difference in GFR in
control periods 1 and 2; nor was there a significant
Fig. 1. Immunoelectrophoresis using antihuman albumin. Well I contained normal human serum. The remaining wells contained 1 l of
protein solutions (4 gIu1) as follows: 2, human albumin (Cutter); 3, cationized human albumin of p1 5.5 to 6.6; 6, cationized human
albumin of p1 7.2 to 8.2; 7, cationized human albumin of p1 7.9 to 8.3; Wells 4 and 5 contained as yet uncharacterized preparations.
-
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Fig. 2. Isoelectric focusing pattern of altered albumin. Optical
density at 280 nm is the absorbancy of the fractions at 280 nm.
Dotted line represents pH of each fraction. Material was iso-
electric focused for 2 days in an ampholyte which formed a
gradient from pH 3 to pH 10. The major albumin fraction was
present in fractions of pH 5.5 to 6.6.
variation with time during the four experimental pe-
riods (Fig. 3 and Table 3). GFR was lower during
the experimental than it was during the control peri-
ods (F1,67 = 65, P < 0.0001). The fall in GFR was
somewhat greater after infusion of altered albumin
than it was after infusion of unaltered albumin, but
the differences were statistically significant (P <
Table 1. Some physical properties of the human albumin
preparations that were infused into ratsa
p1
Molecular weight
daltons
Stokes radius
A
4.9 69,000 35
5.5 to 6.6 69,000 33
7.2 to 8.2 69,000 33
a The p1 (isoelectric point) was measured by isoelectric focus-
ing; molecular weight, by sodium dodecyl sulfate polyacrylamide
gel electrophoresis; and Stokes radius, by Sephadex G-100 chro-
matography.
0.01) only for animals infused with the more highly
cationized derivative (p1, 7.2 to 8.2).
The concentration of rat serum albumin de-
creased somewhat in the experimental period in all
three infused groups (Fig. 4), presumably associat-
ed with the volume expansion. As expected, the
concentration in serum of the infused human albu-
min and albumin derivatives decreased significantly
over the 105-mm following completion of the in-
fusion. There was no difference in the slope of the
curves over the period of observation.
The rate of excretion of the several species of al-
bumin (UAU)V) is also shown in Fig. 4. Of particular
note was the increase in excretion of endogenous
rat albumin as well as of infused human albumin
when the more highly cationized species (p1 of 7.2
to 8.2) was infused. For the clearance of rat albu-
min, there were no significant differences between
the two control periods (Table 3). In the three
Table 2. Experimental data on one animal infused with 40mg of albumin, p17.2 to 8.2"
MAP C
Time Pe- mm V ml! SRA SHA U,,V UHAV
mm Events nods Hg 1d/min mm mg/mi mg/mi p.g/min p.g/min
//
mm
C,
j.d/min %
Cap.T
%
C1
CRA
Co,m
x 100
C,fl
TcH,O
xlOO
C,,, Fe1
Surgery
0 Priming dose 3H inulin at 4.5 jiCi in 0.75 nI normal saline per 1.5 mm
Maintain 3H inulin at 3 Ci in 0.5 ml normal saline per hour
60 Empty bladder
SC1 Cl 127 2.39 23.0
UC1 3.82 1.32SC2 C2 130 0.91 25.0
0.06
0.07
0.0025
0.0077
1.1
2.7
0.9
2.3
0.13
0.47
120 UC2 3.76 1.77
-+
SE1 El 127 0.44 22.2 8.82
UE1 4.61 4.61 193.6
SE2 E2 122 0.88 22.5 4.46
0.21
0.38
21.96
34.25
0.022
0.043
4.99
3.86
104.6
90.1
4.6
3.3
3.5
1.8
1.12
1.80
180 UE2 13.29 8.64 152.8
SE3 E3 110 1.14 21.5 2.58
UE3 29.97 2.46 7.94 13.6SE4 E4 117 0.88 21.0
0.37
0.26
5.25
1.29
0.032
0.030
0.46
0.16
14.2
4.9
4.8
7.5
2.2
3.7
2.79
4.82
240 UE4 33.02 5.55 3.2
Nephrectomy
a Abbreviations used are: MAP, blood pressure at left femoral artery; V, urine excretion rate; C,,,, inulin clearance; SRA, serum level of
rat albumin; SHA, serum level of human albumin; URAV, excretion rate of rat albumin; UHAV, excretion rate of human albumin; CRA, rat
albumin clearance; CHA, human albumin clearance; S, serum; C, control; U, urine; E, experimental; Cosm, osmolar clearance; TcH,O,
free water reabsorption; FENa, fractional excretion of sodium; —*, infusion of 40 mg albumin. Body weight of rat at 0 mm was 248.3 g.
0.
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groups as a whole, rat albumin clearance was great-
er during the four experimental (mean, 0.0125 pu
mm) than it was during the two control (mean,
0.0029 p1/mm) periods (F1,57 = 17; P <0.0001). In
the experimental periods there was no significant
change in rat albumin clearance with time (F3,17 =
0.77; P = 0.52), but there was a highly significant
difference in rat albumin clearances and clearance
ratios between the three infusion groups (F2,9 =
25.8; P < 0.0001). The within-group comparisons
showed that the rat albumin clearances of the group
receiving the albumin derivatives of p1 7.2 to 8.2
differed significantly (P < 0.01) from those in both
the group receiving derivatized albumin with a p1 of
5.5 to 6.6, and the group receiving native albumin.
The clearance ratio of rat albumin (CAIb/Cin)
changed little in the rats receiving unaltered human
albumin (Fig. 4) (average, 0.0069%); that of the rats
receiving derivatized human albumin of p1 5.5 to 6.6
also varied little except in the first experimental pe-
riod. In contrast, the clearance ratio of those ani-
mals receiving albumin of p1 7.2 to 8.2 was in-
creased 14-fold over the control values in these ani-
mals. For the clearance of the infused human
albumins (Table 3), there were clearly significant
differences among the three groups (F2,9 = 34.3, P <
0.0001). Within-group comparisons showed that the
clearance of albumin of p1 7.2 to 8.2 was significant-
— —a—
—a
o.—o p1 4.9
e-—.• p1 5.5-6.6
•—--• p1 7.2-8.2
o-i—a-_.T'a' ._..-a- •-• •-
I I I
150
S
S
a-
100
50
.8 30
>
10
8
8
4
8
4
4
24
z
UJ
U-
,.
/
1 2 1 2 3 4 1 2 1 2 3 4
Control Experimental Control Experimental
Fig. 3. Summary of selected physiologic data on 5 rats infused (arrow) with normal human albumin p14.9 (O—O),4 rats infused with
albumin p1 5.5-6.6 (C----C), and 5 rats infused with altered albumin p1 7.2-8.2 (S-'-'-•).
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Table 3. Summary of results of covariance analysis'
Effect analyzed GFR Rat albumin clearance Human albumin clearance
Control periods I vs. 2 NS NS NS
Control periods (1 + 2) vs. experimental periods F1,67 = 65.05 F1,57 = 17.02(1+2+3+4) P<0.0001 P<0.0001
Covariate (control vs. experimental periods) F1,10 = 6.31
P=0.03
F1,9 = 9.16
P<0.01
Treatment groups F3,19 = 7.49
P<0,01
F2,9 = 25.85
P<0,0001
F29 = 34.35
p<0.0001
Within-group comparisons
p14.9vs.p15.5-6.6 NS NS S
p14.9 vs. p17.2-8.2 S S S
p15.5—6.6 vs. p17.2—8.2 S S S
Timebetweenexperimentalperiods F3, = 1.06P = 0.38 F317
0.77
P = 0.52
F3,17 = 1.81
P = 0.18
Treatment group x time interactions F6,33 = 1.58
P = 0.19
F4,17 = 0.91
P = 0.48
F4,17 = 4.07
P = 0.02
a Differences are significant (5) or not significant (NS).
21 Analyzed by the Duncan Test.
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Fig. 4. Summary of data on the handling of the infused human (HA) and endogenous rat (RA) albumins. Symbols are defined in Fig. 3.
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ly greater (P < 0.01) than that of p1 5.5 to 6.6,
which, in turn, was greater (P <0.01) than that of
unaltered human albumin. Within the four experi-
mental periods as a whole, there was little dif-
ference in the clearance of the human albumin spe-
cies (F3,17 = 1.81, P = 0.18), but there was some
difference in clearance with time among the groups;
(F4,17 = 4.07, P = 0.02).
The geometric mean human albumin (CAIb/CIn)
clearance ratio (Fig. 4) in the rats receiving native
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Table 4. Localization in the rat kidney of human albumin and of the altered human albuminsa
p1 of albumin infused
Glomeruli Tubules
Mesangium Basement membrane Bowman's capsule Droplets Basement membrane
4.9 0 0 0 0 0
5.5to6.6 0 0 0 0
7.2to8.2
Graded semiquantitatively on a scale from 0 to + + + +
albumin (0.0048%) was similar to that of endoge-
nous rat albumin. The clearance ratio for altered hu-
man albumin in rats receiving human albumin of p1
5.5 to 6.6 was much greater (0.013 and 0.011% in the
first and second experimental periods). It was con-
siderably higher than this in rats infused with al-
tered albumin of p1 7.2 to 8.2 (0.74, 4.5, 0.55, and
0.13% in the four experimental periods). When the
clearances of the human and rat albumins were
compared, it was observed that the ratio Chuman Aib'
Crat Ath was close to 1 for animals infused with unal-
tered human albumin; it was 8 to 10 for those re-
ceiving albumin of p1 5.5 to 6.6, and, in the initial
periods, following infusion of albumin of p1 7.2 to
8.2, it was 19 to 64. The results of the immuno-
fluorescence studies are shown in Table 4 and Fig.
5. After infusion of albumin of low p1, human albu-
min could not be detected. In those rats receiv-
ing albumin of p1 5.5 to 6.6, there was equivocal
droplet formation in tubules. In the rats receiving
albumin p1 7.2 to 8.2, there was uptake of human
albumin by the mesangium, 2+ staining of the gb-
merular basement membrane and of Bowman's cap-
sule, droplets in the tubules, and marked fluores-
cence of the tubular basement membrane.
Discussion
It would have been ideal to infuse the normal and
altered human albumins at a constant rate. The dif-
ficulties in making large enough amounts of material
available and in making measurements in urine
when the concentrations are relatively low pre-
cluded this. Studies with polysaccharide macromol-
ecules of narrow size ranges were done with contin-
uous infusion by Wallenius, who showed that in the
dog neutral dextrans of molecular radius less than
23 A had clearances approaching the glomerular fil-
tration rate; that the clearance decreased sharply as
the molecular radius of the dextrans increased from
23 to 34 A; and that for molecules whose radius ex-
ceeded 34 A, the clearance was only a minute frac-
tion of the gbomerular filtration rate [19]. When
polydisperse polysaccharide macromolecules are
infused, as has been done in recent years, the small
macromolecules are excreted relatively rapidly, and
the large molecules relatively slowly. Thus, even
when constant infusions are being given, the plasma
levels must be changing during the experiment.
The results of the present experiments show
clearly, despite a coefficient of variation of 20% in
the assays, that as the isoelectric point is increased
the excretion rate of albumin increases by orders of
magnitude. It is possible that the increase in clear-
ance of the altered albumins is due to the slight de-
crease in molecular radius from 35 A to 33 A. As
the molecular size of both altered albumins was 33
A and the more highly cationized derivative was
cleared more rapidly, the slight decrease in molecu-
lar size cannot be the sole explanation, and the
charge difference would appear to be important.
Failure of tubular reabsorption alone cannot ac-
count for the marked increase in excretion and frac-
tional clearance of the albumin of p1 7.2 to 8.2, be-
cause the difference in the clearance ratio of this
derivative as compared with unaltered albumin is at
least three orders of magnitude larger.
Table 5 is an attempt to summarize briefly the
types of experiments that have been reported by in-
vestigators seeking to study the permeability to
macromolecules of the glomerular capillary wall.
For many years, experiments were done that ad-
dressed the importance of the molecular weight or
Stokes radius of the macromolecule [20]. Various
polysaccharide macromolecules, vegetable pro-
teins, ferritin, and nonplasma proteins were used.
Glomerular permeability was assessed physiologi-
cally (using clearance measurements) or morpho-
logically. The tracers used were chosen, not primar-
ily because they were valid analogs of the major hu-
man plasma protein albumin, but rather because
they had certain characteristics, for example, elec-
tron density, peroxidase activity, or absence of
tubular reabsorption, that enabled them to be mea-
sured.
Evidence that the glomerular basement mem-
brane was a major barrier to filtration came from
ferritin studies by Farquhar, Wissig, and Palade [4].
An alternative view, that placed major importance
on the slit pore, came from the studies on proteins
with peroxidase activity by Graham and Karnovsky
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Fig. 5. A Immunofluorescent study of renal cortex of rat infused with altered human albumin of p1 7.2 to 8.2 showing linear staining of
glomerular basement membrane with fluorescein conjugated antisera to normal human albumin x 1320. B Immunofluorescence study
from same rat showing that material immunoreactive with antisera to human albumin is present both as droplets within tubular cyto-
plasma and in tubular lumen (X320). C Section of outer medulla from same rat showing intense fluorescence of tubular membrane
(x320).
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Table 5. Interpretative summary of experiments designed to examine the interrelationship between glomerular permeability and certain
characteristics of protein and polysaccharide tracer moleculesa
Macromolecular tracer
Experimental approach Morphologic changes
Exogenous tracer Endogenous
albumin
control
Foot
process
effacement
Glomerular
polyanion
Binding
of tracer ReferencesMorphologic Physiologic
Molecular size, Stokes radius
Unaltered animal and vegetable proteins Yes Yes No Absent ND Yes 5, 6,8,21
ofmolecularradius 19to61 A (Ly) (Ly)
(HRP) (HRP)
(Ly,CAT
LAC)
22, 23
Dextrans Yes Yes No None ND None 19, 20
Polyion charge
Dextrans No Yes No ND ND ND 1, 2
Systematically altered animal and
vegetable proteins (FER, CAT, HRP) Yes Yes No None ND Yes, if
p1>7
3, 7
Systematically altered albumin Yesb Yes Yes Yesb Presentb Yes This study
a Abbreviations used are: CAT, catalase; FER, ferritin; HRP, horseradish peroxidase; LAC, lactoperoxidase; Ly, lysozyme; ND, not
done.
b Clyne et al, unpublished observations.
[6] and Graham and Kellermeyer [8]. These studies
were done before it was appreciated that the electri-
cal charge on a macromolecule might also be impor-
tant [1, 2, 21]. As this concept gained acceptance, it
was realized that most of the tracer proteins with
peroxidase activity had apT > 7, and they were then
shown to be capable of binding to negatively
charged structures in the glomeruli [7, 21]. Presum-
ably, such binding may itself result in change in the
functional integrity of the glomerulus.
Lysozyme (p1, 11), which has been used exten-
sively in physiologic studies [22], has been shown
also to bind extensively to negatively charged struc-
tures in glomeruli and tubules [23]. Such extensive
binding makes it very difficult to interpret the mean-
ing of clearance measurements with this protein.
Alterations in the glomerular integrity to macromol-
ecules may presumably be reflected in alterations in
the handling of endogenous plasma proteins and
particularly albumin, but this was not studied in any
of the experiments described.
Table 5 also summarizes the experiments done
with a view to examining the influence of electrical
charge on the macromolecule. Studies with dex-
trans showed the influence of charge on their trans-
port, but were limited to clearance measurements.
Recently, several proteins, that are either electron-
dense or have peroxidase activity, have been modi-
fied to produce protein species with various isoelec-
tric points [3, 7]. Clearance studies have shown that
positively charged proteins are more readily trans-
ported through the glomerular capillary wall; mor-
phologic studies, that cationic protein may bind to
glomerular structures.
The present study is, to our knowledge, the only
study in which an important endogenous and analo-
gous protein has been studied, namely the animal's
own albumin. The data show that increasing the
isoelectric point of the heterologous albumin caused
not only an increase in heterologous albumin excre-
tion, but also increased nephron permeability to na-
tive endogenous albumin. This implies that a
change in the functional structure of the nephron
has occurred. Immunofluorescent microscopic
studies show binding of the highly cationized albu-
min in the glomerulus, probably to sialoprotein.
Studies in our laboratory, to be reported separately,
also show focal effacement of foot processes (Clyne
et al, in preparation).
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